Literature DB >> 7785911

Expression of osteopontin in a macrophage cell line and in transgenic mice with pulmonary fibrosis resulting from the lung expression of a tumor necrosis factor-alpha transgene.

Y Miyazaki1, T Tashiro, Y Higuchi, M Setoguchi, S Yamamoto, H Nagai, M Nasu, P Vassalli.   

Abstract

The expression level of osteopontin (OPN) mRNA was found to be increased in a macrophage cell line in the presence of recombinant tumor necrosis factor-alpha (TNF-alpha). OPN mRNA level was also explored in the lungs of transgenic mice which were expressing TNF-alpha in type II pneumocytes, a condition leading to pulmonary alveolitis and progressive fibrosis. OPN mRNA was significantly increased in the lungs of these transgenic mice. In situ hybridization showed that it was localized mostly in alveolar macrophages. Since OPN can be induced in macrophages by TNF-alpha stimulation and since on the other hand osteopontin appears to decrease the level of nitric oxide synthase, and thus the production of nitric oxide, osteopontin might also indirectly have an antifibrotic effect. The role played by osteopontin in fibrotic lesions resulting from the release of TNF-alpha deserves further study, since it may be involved in the balance of opposite effects eventually leading to local tissue damage ending in fibrosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7785911     DOI: 10.1111/j.1749-6632.1995.tb44651.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  9 in total

1.  Osteopontin expression in ductal adenocarcinomas and undifferentiated carcinomas of the pancreas.

Authors:  R Sedivy; K Peters; G Klöppel
Journal:  Virchows Arch       Date:  2004-11-26       Impact factor: 4.064

2.  Absence of specific alternatively spliced exon of CD44 in macrophages prevents colitis.

Authors:  B M Wittig; R Sabat; P Holzlöhner; E Witte-Händel; K Heilmann; K Witte; J Triebus; A Tzankov; J D Laman; B Bokemeyer; L Terracciano; C Schwärzler; H Kohler; R Volkmer; C Loddenkemper; K Wolk; U Hoffmann; U Günthert
Journal:  Mucosal Immunol       Date:  2017-11-29       Impact factor: 7.313

Review 3.  Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation.

Authors:  A O'Regan; J S Berman
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

4.  Role of tumor necrosis factor-alpha in the spontaneous development of pulmonary fibrosis in viable motheaten mutant mice.

Authors:  R S Thrall; S N Vogel; R Evans; L D Shultz
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

5.  Osteopontin is strongly expressed by alveolar macrophages in the lungs of acute respiratory distress syndrome.

Authors:  Fumiyuki Takahashi; Kazuhisa Takahashi; Kazue Shimizu; Ri Cui; Norihiro Tada; Hideki Takahashi; Sanae Soma; Masakata Yoshioka; Yoshinosuke Fukuchi
Journal:  Lung       Date:  2004       Impact factor: 2.584

6.  Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis.

Authors:  Nobuchika Yamamoto; Fumihiko Sakai; Shigeyuki Kon; Junko Morimoto; Chiemi Kimura; Harumi Yamazaki; Ikuko Okazaki; Nobuo Seki; Takashi Fujii; Toshimitsu Uede
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

7.  Role of osteopontin in neutrophil function.

Authors:  Adeline Koh; Andre Paes Batista da Silva; Anil K Bansal; Manju Bansal; Chunxiang Sun; Hyejin Lee; Michael Glogauer; Jaro Sodek; Ron Zohar
Journal:  Immunology       Date:  2007-08-03       Impact factor: 7.397

8.  Cell stress induces upregulation of osteopontin via the ERK pathway in type II alveolar epithelial cells.

Authors:  Aki Kato; Takafumi Okura; Chizuru Hamada; Seigo Miyoshi; Hitoshi Katayama; Jitsuo Higaki; Ryoji Ito
Journal:  PLoS One       Date:  2014-06-25       Impact factor: 3.240

9.  Secreted Phosphoprotein 1 and Sex-Specific Differences in Silica-Induced Pulmonary Fibrosis in Mice.

Authors:  Joseph D Latoche; Alexander Chukwuma Ufelle; Fabrizio Fazzi; Koustav Ganguly; George D Leikauf; Cheryl L Fattman
Journal:  Environ Health Perspect       Date:  2016-03-08       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.